Steve Richards

Steve Richards has a diverse work experience in the pharmaceutical industry and academia. Steve most recently worked as an Associate Director of Clinical Science at Zentalis Pharmaceuticals since June 2023. Prior to that, they were an Associate Director of Clinical Science at Merck from November 2021 to June 2023. Steve also served as a Senior Clinical Scientist at Acceleron Pharma from November 2020 to November 2021. Steve has experience at Novartis Institutes for BioMedical Research (NIBR) where they held various roles including Head of Emerging Technology Strategy, and PMO, NIBR Quality from June 2019 to November 2020. Steve was also an Investigator and Postdoctoral Fellow in Biomarker Development at NIBR. Additionally, Steve has academic experience as an Associate Professor at MCPHS University from July 2015 to June 2019, and as a Pharmaceutical Sciences Research Fellow at MCPHS from March 2013 to May 2015. Steve also served as an Arts & Sciences Research Fellow at the University of Richmond from May 2009 to August 2011.

Steve Richards completed their education with a Doctor of Pharmacy (Pharm.D.) degree from Massachusetts College of Pharmacy and Health Sciences in 2015. Prior to that, they obtained a Bachelor of Science (BS) degree in Biology from the University of Richmond in 2012. Additionally, they attended Boston College High School, but no specific degree or field of study information is provided.